An announcement made by FDA Director Stephen Hahn on the
possibility of the issuance of emergency use authorization for COVID-19
vaccines without their developers completing Phase III trials has triggered a
response from the World Health Organization cautioning that such a decision
would require a "great deal of seriousness and reflection," according
to WHO Chief Scientist Soumya Swaminathan. The WHO recommends that a full set
of data be used for vaccines' pre-qualification, Swaminathan said.
No comments:
Post a Comment